Clin2
NCT07626437Possibly a fitRecruiting

Cold and Flu Symptom Relief Medicine Trial

Common Cold/FluNasal CongestionNasal Obstruction

Part of Ear, nose & throat, Infections, Lungs & breathing clinical trials.

This study tests a combination medicine containing pain reliever, caffeine, and allergy medication to help ease nasal congestion and other cold or flu symptoms. You'd take the medicine for a short period and report how well it works.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
620 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • Age 18–60 years old
  • Symptoms of nasal congestion or stuffy nose from a cold or flu that started less than 48 hours ago and are moderate to severe
  • Haven't taken any other cold or flu medicines yet
  • No COVID-19 infection or recent COVID exposure (within 14 days)
  • No serious medical conditions like asthma, heart disease, blood disorders, or immune system problems
  • Women: not pregnant, not breastfeeding, and using birth control if able to become pregnant

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06830109Recruiting· Phase 2
Testing a nasal spray for stuffy nose relief

This study tests if a combination of two nasal sprays (a decongestant and a steroid) can help people with chronic nasal blockage who haven't gotten relief from steroid sprays alone.

St Louis, Missouri
NCT07620522Not yet recruiting
Nasal spray study for sudden nasal blockage

This study looks at how well a nasal spray called RHINOSEDAL works for people whose nose suddenly gets blocked, such as from a cold, allergies, or sinus trouble. It aims to see if the spray helps relieve the blockage within 48 hours of it starting.

Multiple Locations
NCT07642648Not yet recruiting· Phase 2
Herbal blend for reducing cold symptoms

This trial tests a herbal blend designed to shorten colds and reduce how bad they feel. It is for generally healthy adults in Australia who get colds often.

NCT07059767Recruiting· Phase 2
Nasal spray for asthma symptoms from colds

This trial tests if an investigational nasal spray (ETH47) can reduce asthma symptoms triggered by a common cold virus (rhinovirus). You will be exposed to the virus in a safe setting to see if the spray helps control your asthma.

London
NCT07383493Recruiting
Treatments for cold and sinus infections

This study tests treatments for the common cold, sinus pain, or sore throat caused by a virus. It compares different options to see which works best for reducing symptoms like runny nose, congestion, and cough.

Clermont-Ferrand
NCT07798193Not yet recruiting· Phase 2
SYH2085 tablet for adults with the flu

This trial tests an oral tablet (SYH2085) to see if it can help adults with the flu feel better faster. If you join, you'll either get the study drug or a placebo (a pill with no medicine).

Hear when a new Nasal Obstruction trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.